查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2112680

全球足底筋膜炎治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Plantar Fasciitis Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 155 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球足底筋膜炎治療市場預計將從2025年的20.7億美元成長至2034年的38.3億美元，2026年至2034年的複合年成長率（CAGR）為7.07%。全球足底筋膜炎治療市場的成長主要歸因於足部疾病、運動傷害和肥胖相關疾病發生率的上升。足底筋膜炎是足跟疼痛的常見原因，特別常見於運動員和老年人。人們對早期診斷和治療方案（如矯正器具、物理治療、藥物治療和微創治療）的認知不斷提高，推動了市場成長。此外，人們參與體育鍛煉的增加也促進了對治療方案需求的成長。

診斷影像和治療設備的科技進步是市場的主要驅動力。包括衝擊波療法和再生醫學在內的創新療法的普及正在改善患者的治療效果。此外，人們對非手術治療的日益關注以及鞋類技術的進步也對市場需求產生了積極影響。醫療機構正著力加強預防保健和復健計劃，以降低復發率。

未來，在生技藥品和個人化治療方法的推動下，市場預計將持續成長。新興市場醫療基礎設施的擴張將進一步加速市場滲透。醫療成本的上漲和肌肉骨骼疾病保險覆蓋範圍的擴大也將發揮重要作用。隨著疼痛管理和組織再生研究的不斷深入，足底筋膜炎治療市場預計將保持持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的關鍵促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本節依據產品類型、應用、最終用戶和地區，將市場系統性地分類為若干關鍵細分市場。它揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以揭示未來發展趨勢。

區域分析：這包括對主要地理區域的市場趨勢進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球足底筋膜炎治療市場：依類型分類

  • 市場分析、洞察與預測
  • 藥物治療
  • 矯正器
  • 衝擊波療法
  • 外科手術
  • 其他

第5章：全球足底筋膜炎治療市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 診所
  • 其他

第6章 全球足底筋膜炎治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Pfizer Inc
    • Algeo Ltd
    • Otto Bock SE & Co
    • Hanger Inc
    • Bayer
    • GlaxoSmithKline Plc
    • Superfeet Worldwide Inc
    • Bauerfeid AG
    • KGaA（Otto Bock Holding）
    • Sanofi
    • Group（Dr. Scholl's）
簡介目錄
Product Code: VMR112113821

The global plantar fasciitis treatment market size is expected to reach USD 3.83 Billion in 2034 from USD 2.07 Billion in 2025, growing at a CAGR of 7.07% during 2026-2034.The Global Plantar Fasciitis Treatment Market is expanding due to the rising incidence of foot disorders, sports injuries, and obesity-related conditions. Plantar fasciitis is a common cause of heel pain, particularly among athletes and aging populations. Growing awareness about early diagnosis and treatment options such as orthotics, physiotherapy, medications, and minimally invasive procedures is supporting market growth. Increasing participation in physical activities also contributes to higher demand for treatment solutions.

Technological advancements in diagnostic imaging and therapeutic devices are key drivers for the market. The availability of innovative treatments, including shockwave therapy and regenerative medicine, is enhancing patient outcomes. Additionally, the increasing focus on non-surgical treatment methods and improved footwear technology is positively influencing demand. Healthcare providers are emphasizing preventive care and rehabilitation programs to reduce recurrence rates.

In the future, the market is expected to witness continued growth supported by advancements in biologics and personalized treatment approaches. Expanding healthcare infrastructure in emerging economies will further accelerate adoption. Rising healthcare expenditure and insurance coverage for musculoskeletal disorders will also play a vital role. As research in pain management and tissue regeneration progresses, the plantar fasciitis treatment market is poised for sustained development.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Medication Therapy
  • Orthotics
  • Shockwave Therapy
  • Surgery
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Center
  • Clinics
  • Others

COMPANIES PROFILED

  • Pfizer Inc., Algeo Ltd., Otto bock SE & Co., Hanger Inc., Bayer, GlaxoSmithKline Plc., Superfeet Worldwide Inc., Bauerfeid AG, KGaA (Otto bock Holding)., Sanofi, Group (Dr. Scholl's)

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Medication Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Orthotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Shockwave Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Ambulatory Surgical Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PLANTAR FASCIITIS TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Type
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PLANTAR FASCIITIS TREATMENT INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Pfizer Inc
    • 8.2.2 Algeo Ltd
    • 8.2.3 Otto Bock SE & Co
    • 8.2.4 Hanger Inc
    • 8.2.5 Bayer
    • 8.2.6 GlaxoSmithKline Plc
    • 8.2.7 Superfeet Worldwide Inc
    • 8.2.8 Bauerfeid AG
    • 8.2.9 KGaA (Otto Bock Holding)
    • 8.2.10 Sanofi
    • 8.2.11 Group (Dr. Scholl's)